Aberdeen Group’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-716,172
Closed -$68.1M 925
2018
Q3
$68.1M Buy
716,172
+551
+0.1% +$47K 0.13% 153
2018
Q2
$55.3M Buy
715,621
+27,919
+4% +$2.09M 0.11% 179
2018
Q1
$47.5M Sell
687,702
-60,728
-8% -$4.63M 0.09% 210
2017
Q4
$55.9M Buy
748,430
+6,413
+0.9% +$410K 0.11% 184
2017
Q3
$47M Buy
+742,017
New +$46.1M 0.09% 219

Other funds holding ESRX

Aberdeen Group's ESRX Position: Q4 2018 in Review

Aberdeen Group sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 716,172 shares — an estimated $68.1M sold.

Aberdeen Group first reported a position in ESRX in Q3 2017 and held it in 5 quarters. The position peaked at $68.1M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Aberdeen Group reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Aberdeen Group sold 716,172 Express Scripts Holding Company shares in Q4 2018, an estimated $68.1M.
  • Aberdeen Group first reported a position in Express Scripts Holding Company in Q3 2017 and held it in 5 quarters.
  • Aberdeen Group's Express Scripts Holding Company position peaked at $68.1M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Aberdeen Group's 13F filing for Q4 2018, filed 12 Feb 2019.